Rankings
▼
Calendar
COLL Q4 2016 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena
COLL
Collegium Pharmaceutical, Inc.
$1B
Q4 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$1M
Gross Profit
$1M
85.9% margin
Operating Income
-$28M
-2116.6% margin
Net Income
-$28M
-2115.0% margin
EPS (Diluted)
$-1.02
QoQ Revenue Growth
+219.4%
Cash Flow
Operating Cash Flow
-$23M
Free Cash Flow
-$24M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$162M
Total Liabilities
$27M
Stockholders' Equity
$135M
Cash & Equivalents
$153M
← FY 2016
All Quarters
Q1 2017 →
